MUKUL PANDIT: Open Payments
NPI 1104815554 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 45 payments from 14 companies in 2025. Trend: 2023 $830 · 2024 $717 · 2025 $975
Food & beverage: $858Education: $117
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $289 |
| Teva Pharmaceuticals USA, Inc. | 5 | $211 |
| Neurocrine BioSciences, Inc. | 4 | $79 |
| GlaxoSmithKline, LLC. | 5 | $77 |
| E.R. Squibb & Sons, L.L.C. | 4 | $77 |
| Exact Sciences Corporation | 3 | $57 |
| ABBVIE INC. | 2 | $34 |
| Lilly USA, LLC | 2 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Lundbeck LLC | 1 | $23 |
Products named: AIRSUPRA, AUSTEDO XR, INGREZZA, TRELEGY ELLIPTA, COBENFY, BREZTRI, FARXIGA, The Cologuard Plus Collection Kit.
Industry payments across OH — which companies pay providers there.
